NYSE:VAR - Varian Medical Systems Stock Price, Price Target & More

Get Started

$122.17 -1.14 (-0.92 %)

(As of 06/17/2018 04:00 PM ET)

Previous Close$122.17

Today's Range$121.91 - $123.1650

52-Week Range$95.23 - $130.29

Volume806,293 shs

Average Volume559,067 shs

Market Capitalization$11.18 billion

P/E Ratio33.94

Dividend YieldN/A

Beta0.85

About Varian Medical Systems (NYSE:VAR)

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Varian Particle Therapy. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. Its products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, and accessories; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, oncology practices, radiotherapy centers, and cancer care clinics. The Varian Particle Therapy segment develops, designs, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. Varian Medical Systems, Inc. has a strategic partnership with Siemens AG to co-develop new imaging and treatment solutions. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.

Receive VAR News and Ratings via Email

Sign-up to receive the latest news and ratings for VAR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment

Sub-IndustryHealth Care Equipment

SectorMedical

SymbolNYSE:VAR

CUSIP92220P10

Webwww.varian.com

Phone650-493-4000

Debt

Debt-to-Equity RatioN/A

Current Ratio1.53

Quick Ratio1.25

Price-To-Earnings

Trailing P/E Ratio33.94

Forward P/E Ratio27.15

P/E Growth3.4

Sales & Book Value

Annual Sales$2.67 billion

Price / Sales4.19

Cash Flow$4.4882 per share

Price / Cash27.22

Book Value$16.33 per share

Price / Book7.48

Profitability

EPS (Most Recent Fiscal Year)$3.60

Net Income$249.60 million

Net Margins4.77%

Return on Equity27.99%

Return on Assets12.51%

Miscellaneous

Employees6,600

Outstanding Shares91,500,000

Varian Medical Systems (NYSE:VAR) Frequently Asked Questions

What is Varian Medical Systems' stock symbol?

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems, Inc. (NYSE:VAR) issued its earnings results on Wednesday, April, 25th. The medical equipment provider reported $1.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.04 by $0.11. The medical equipment provider earned $729.90 million during the quarter, compared to the consensus estimate of $685.86 million. Varian Medical Systems had a return on equity of 27.99% and a net margin of 4.77%. The company's revenue for the quarter was up 10.1% on a year-over-year basis. During the same period in the prior year, the business posted $0.89 EPS. View Varian Medical Systems' Earnings History.

When is Varian Medical Systems' next earnings date?

Varian Medical Systems is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Varian Medical Systems.

What guidance has Varian Medical Systems issued on next quarter's earnings?

Varian Medical Systems updated its FY18 earnings guidance on Wednesday, April, 25th. The company provided earnings per share guidance of $4.43-4.53 for the period, compared to the Thomson Reuters consensus estimate of $4.40. The company issued revenue guidance of +6-9% (Approx $3.11-3.21 billion), compared to the consensus revenue estimate of $2.79 billion.

What price target have analysts set for VAR?

8 brokers have issued 12 month price targets for Varian Medical Systems' stock. Their predictions range from $98.00 to $132.00. On average, they anticipate Varian Medical Systems' share price to reach $111.2857 in the next year. View Analyst Ratings for Varian Medical Systems.

Who are some of Varian Medical Systems' key competitors?

Some companies that are related to Varian Medical Systems include SONOVA Hldg AG/ADR (SONVY), Masimo (MASI), LivaNova (LIVN), GETINGE AB/ADR (GNGBY), CONMED (CNMD), NxStage Medical (NXTM), AxoGen (AXGN), Natus Medical (BABY), Cutera (CUTR), Viewray (VRAY), Rockwell Medical (RMTI), Vision Sciences (CGNT), BioLife Solutions (BLFS), Helius Medical Technologies (HSDT) and Fonar (FONR).

Who are Varian Medical Systems' key executives?

Varian Medical Systems' management team includes the folowing people:

Mr. Gary E. Bischoping Jr., Sr. VP of Fin. & CFO (Age 50)
Mr. Dow R. Wilson, Pres, CEO & Director (Age 59)
Mr. Patrick Joda, Sr. VP of Global Operations (Age 60)
Mr. Magnus A. Momsen, Sr. VP, Chief Accounting Officer & Corp. Controller
Mr. Corey Zankowski Ph.D., Chief Technology Innovation Officer and Sr. VP

Has Varian Medical Systems been receiving favorable news coverage?

News coverage about VAR stock has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Varian Medical Systems earned a media sentiment score of 0.13 on Accern's scale. They also gave headlines about the medical equipment provider an impact score of 45.80 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future.

Who are Varian Medical Systems' major shareholders?

Varian Medical Systems' stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.76%), Loomis Sayles & Co. L P (6.91%), First Eagle Investment Management LLC (5.17%), Fiera Capital Corp (2.66%), Alecta Pensionsforsakring Omsesidigt (1.88%) and Northern Trust Corp (1.55%). Company insiders that own Varian Medical Systems stock include Clarence R Verhoef, David J Illingworth, Dow R Wilson, Elisha W Finney, John W Kuo, Kolleen T Kennedy, Magnus Momsen, Mark R Laret, R Andrew Eckert, Susan L Bostrom and Timothy E Guertin. View Institutional Ownership Trends for Varian Medical Systems.

Which institutional investors are selling Varian Medical Systems stock?

VAR stock was sold by a variety of institutional investors in the last quarter, including Loomis Sayles & Co. L P, Alecta Pensionsforsakring Omsesidigt, American Century Companies Inc., Envestnet Asset Management Inc., JPMorgan Chase & Co., United Capital Financial Advisers LLC, Stifel Financial Corp and Saratoga Research & Investment Management. Company insiders that have sold Varian Medical Systems company stock in the last year include David J Illingworth, Dow R Wilson, John W Kuo, Kolleen T Kennedy, Magnus Momsen, Mark R Laret, R Andrew Eckert, Susan L Bostrom and Timothy E Guertin. View Insider Buying and Selling for Varian Medical Systems.

Which institutional investors are buying Varian Medical Systems stock?

VAR stock was acquired by a variety of institutional investors in the last quarter, including Schwab Charles Investment Management Inc., Millennium Management LLC, Chicago Equity Partners LLC, Russell Investments Group Ltd., Summit Trail Advisors LLC, Schroder Investment Management Group, Legal & General Group Plc and Royal Bank of Canada. View Insider Buying and Selling for Varian Medical Systems.

How do I buy shares of Varian Medical Systems?

Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Varian Medical Systems' stock price today?

One share of VAR stock can currently be purchased for approximately $122.17.

How big of a company is Varian Medical Systems?

Varian Medical Systems has a market capitalization of $11.18 billion and generates $2.67 billion in revenue each year. The medical equipment provider earns $249.60 million in net income (profit) each year or $3.60 on an earnings per share basis. Varian Medical Systems employs 6,600 workers across the globe.

How can I contact Varian Medical Systems?

Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]

MarketBeat Community Rating for Varian Medical Systems (VAR)

Community Ranking:		2.6 out of 5 ( )
Outperform Votes:		376 (Vote Outperform)
Underperform Votes:		340 (Vote Underperform)
Total Votes:		716

MarketBeat's community ratings are surveys of what our community members think about Varian Medical Systems and other stocks. Vote "Outperform" if you believe VAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VAR will underperform the S&P 500 over the long term. You may vote once every thirty days.

Varian Medical Systems (NYSE:VAR) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

8 Wall Street analysts have issued ratings and price targets for Varian Medical Systems in the last 12 months. Their average twelve-month price target is $111.2857, suggesting that the stock has a possible downside of 8.91%. The high price target for VAR is $132.00 and the low price target for VAR is $98.00. There are currently 2 sell ratings, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Hold	Hold
Consensus Rating Score:	2.00	2.00	2.00	1.90
Ratings Breakdown:	2 Sell Rating(s) 4 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 4 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	3 Sell Rating(s) 5 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 7 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$111.2857	$111.2857	$108.4444	$98.3889
Price Target Upside:	8.91% downside	7.89% downside	16.23% downside	11.54% downside

Varian Medical Systems (NYSE:VAR) Consensus Price Target History

Price Target History for Varian Medical Systems (NYSE:VAR)

Varian Medical Systems (NYSE:VAR) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/10/2018	Royal Bank of Canada	Set Price Target	Hold	$115.00	Low
1/28/2018	BTIG Research	Reiterated Rating	Neutral ➝ Hold		Low
1/25/2018	JPMorgan Chase & Co.	Boost Price Target	Neutral ➝ Neutral	$88.00 ➝ $105.00	Low
1/25/2018	Barrington Research	Upgrade	Market Perform ➝ Outperform	$130.00	High
1/25/2018	Citigroup	Boost Price Target	Neutral ➝ Buy	$128.00 ➝ $132.00	High
1/25/2018	Goldman Sachs Group	Downgrade	Neutral ➝ Sell	$98.00	High
1/3/2018	Evercore ISI	Initiated Coverage	Underperform ➝ Underperform	$100.00	Low
8/28/2017	Robert W. Baird	Reiterated Rating	Hold	$99.00	Low
5/17/2017	Aegis	Reiterated Rating	Hold	$91.00	Low
5/11/2017	Jefferies Financial Group	Reiterated Rating	Buy		Low
4/24/2017	Off Wall Street	Initiated Coverage	Sell		Low
7/28/2016	Morgan Stanley	Boost Price Target	Underweight	$80.00 ➝ $86.00	N/A
7/28/2016	Brean Capital	Boost Price Target	Buy	$87.00 ➝ $90.00	N/A

(Data available from 6/17/2016 forward)

Varian Medical Systems (NYSE:VAR) Earnings History and Estimates Chart

Earnings by Quarter for Varian Medical Systems (NYSE:VAR)

Varian Medical Systems (NYSE:VAR) Earnings Estimates

2018 EPS Consensus Estimate: $4.22

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	2	$0.92	$1.00	$0.96
Q2 2018	2	$0.94	$1.03	$0.99
Q3 2018	2	$1.01	$1.05	$1.03
Q4 2018	2	$1.23	$1.26	$1.25

Varian Medical Systems (NYSE VAR) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
7/24/2018		$1.00					N/A
4/25/2018	Q2 2018	$1.04	$1.15	$685.86 million	$729.90 million	View	N/A
1/24/2018	Q1 2018	$1.00	$1.06	$633.96 million	$678.50 million	View	Listen
10/25/2017	Q4 2017	$1.19	$1.09	$741.69 million	$739.00 million	View	N/A
7/26/2017	Q3 2017	$0.95	$1.04	$663.86 million	$662.40 million	View	N/A
4/26/2017	Q2 2017	$0.88	$0.89	$639.26 million	$655.00 million	View	N/A
1/25/2017	Q1 2017	$1.05	$0.75	$768.62 million	$763.30 million	View	N/A
10/26/2016	Q4112	$1.34	$1.38	$880.29 million	$912.00 million	View	Listen
7/27/2016	Q316	$1.17	$1.22	$779.90 million	$789.40 million	View	Listen
4/27/2016	Q216	$1.08	$1.09	$769.56 million	$758.80 million	View	Listen
1/27/2016	Q116	$0.94	$0.99	$748.01 million	$757.00 million	View	Listen
10/28/2015	Q4	$1.10	$1.04	$813.18 million	$817.80 million	View	Listen
7/29/2015	Q3	$1.0980	$1.13	$810.41 million	$784.00 million	View	Listen
4/29/2015	Q215	$1.00	$1.05	$799.66 million	$759.40 million	View	N/A
1/28/2015	Q115	$0.87	$0.99	$720.83 million	$737.90 million	View	N/A
10/22/2014	Q415	$1.21	$1.02	$837.86 million	$812.10 million	View	Listen
7/23/2014	Q314	$1.09	$1.08	$767.52 million	$747.70 million	View	N/A
4/23/2014	Q4112	$1.03	$1.04	$772.84 million	$779.00 million	View	N/A
1/22/2014	Q3112	$0.90	$0.91	$718.23 million	$712.00 million	View	N/A
10/23/2013	Q3112	$1.12	$1.08	$779.02 million	$770.00 million	View	N/A
7/24/2013	Q3 2013	$1.01	$1.03	$749.01 million	$726.20 million	View	N/A
4/24/2013	Q2 2013	$1.02	$1.04	$758.02 million	$768.40 million	View	N/A
1/23/2013	Q1 2013	$0.87	$0.86	$676.15 million	$678.40 million	View	N/A
10/25/2012		$1.03	$1.08			View	N/A
7/25/2012		$0.94	$0.96			View	N/A
4/25/2012		$0.96	$0.96			View	N/A
1/25/2012		$0.75	$0.79			View	N/A
10/27/2011		$0.97	$0.95			View	N/A
7/27/2011		$0.83	$0.83			View	N/A
4/27/2011		$0.85	$0.86			View	N/A
1/26/2011		$0.73	$0.80			View	N/A
10/28/2010	Q4 2010	$0.84	$0.87			View	N/A
7/28/2010	Q3 2010	$0.65	$0.74			View	N/A
4/28/2010	Q2 2010	$0.68	$0.73			View	N/A
1/27/2010	Q1 2010	$0.56	$0.63			View	N/A
10/29/2009	Q4 2009	$0.75	$0.78			View	N/A
7/29/2009	Q3 2009	$0.63	$0.68			View	N/A
4/29/2009	Q2 2009	$0.60	$0.64			View	N/A
1/29/2009	Q1 2009	$0.51	$0.56			View	N/A
10/23/2008	Q4 2008	$0.65	$0.68			View	N/A
7/23/2008	Q3 2008	$0.46	$0.58			View	N/A
4/23/2008	Q2 2008	$0.51	$0.56			View	N/A
1/23/2008	Q1 2008	$0.40	$0.43			View	N/A

(Earnings results data provided by Zacks Investment Research)

Varian Medical Systems (NYSE:VAR) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Varian Medical Systems (NYSE VAR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.78%
Institutional Ownership Percentage: 93.74%

Insider Trading History for Varian Medical Systems (NYSE:VAR)

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Varian Medical Systems (NYSE VAR) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/15/2018	John W Kuo	SVP	Sell	1,327	$117.15	$155,458.05	30,551
5/10/2018	Kolleen T Kennedy	EVP	Sell	699	$118.20	$82,621.80	27,555
4/16/2018	John W Kuo	SVP	Sell	1,328	$121.94	$161,936.32	30,708
4/10/2018	Kolleen T Kennedy	EVP	Sell	699	$120.33	$84,110.67	27,361
3/15/2018	John W Kuo	SVP	Sell	1,328	$125.51	$166,677.28	30,708
3/12/2018	Kolleen T Kennedy	EVP	Sell	699	$126.47	$88,402.53	27,361
3/12/2018	Magnus Momsen	CAO	Sell	1,556	$126.47	$196,787.32	6,588
3/6/2018	David J Illingworth	Director	Sell	5,651	$122.56	$692,586.56	12,737
3/1/2018	Dow R Wilson	Insider	Sell	24,000	$118.03	$2,832,720.00	99,356
2/22/2018	Susan L Bostrom	Director	Sell	1,952	$120.60	$235,411.20	3,809
2/16/2018	Kolleen T Kennedy	EVP	Sell	3,513	$121.16	$425,635.08	28,899
2/15/2018	John W Kuo	SVP	Sell	6,442	$120.67	$777,356.14	28,224
2/12/2018	Kolleen T Kennedy	EVP	Sell	8,390	$116.47	$977,183.30	35,052
2/1/2018	Dow R Wilson	Insider	Sell	24,000	$126.73	$3,041,520.00	90,776
2/1/2018	Mark R. Laret	Director	Sell	2,161	$126.97	$274,382.17
1/16/2018	John W Kuo	SVP	Sell	863	$108.43	$93,575.09	28,224
1/16/2018	Kolleen T Kennedy	EVP	Sell	933	$108.31	$101,053.23	27,595
1/12/2018	Kolleen T Kennedy	EVP	Sell	1,089	$108.19	$117,818.91	27,751
1/8/2018	John W Kuo	SVP	Sell	7,991	$110.65	$884,204.15	27,363
1/2/2018	Timothy E Guertin	Director	Sell	10,000	$111.46	$1,114,600.00	2,161
12/18/2017	Dow R Wilson	Insider	Sell	88,766	$111.00	$9,853,026.00	155,542
12/13/2017	Kolleen T Kennedy	EVP	Sell	2,018	$111.97	$225,955.46	27,749
11/13/2017	Kolleen T Kennedy	EVP	Sell	2,021	$107.36	$216,974.56	27,595
10/18/2017	Kolleen T Kennedy	EVP	Sell	931	$105.00	$97,755.00	27,531
10/12/2017	Kolleen T Kennedy	EVP	Sell	1,088	$101.55	$110,486.40
10/6/2017	Dow R Wilson	Insider	Sell	15,059	$102.40	$1,542,041.60
10/6/2017	R Andrew Eckert	Director	Sell	5,651	$102.39	$578,605.89
9/13/2017	Kolleen T Kennedy	EVP	Sell	933	$107.29	$100,101.57	27,533
9/12/2017	Kolleen T Kennedy	EVP	Sell	1,088	$107.33	$116,775.04	27,688
9/7/2017	Dow R Wilson	Insider	Sell	15,059	$105.41	$1,587,369.19	81,835
8/31/2017	Kolleen T Kennedy	EVP	Sell	931	$105.00	$97,755.00	27,531
8/14/2017	Kolleen T Kennedy	EVP	Sell	1,088	$97.91	$106,526.08	26,600
8/7/2017	Dow R Wilson	Insider	Sell	15,059	$96.48	$1,452,892.32	81,835
7/13/2017	John W Kuo	SVP	Sell	1,597	$104.43	$166,774.71	28,224
7/13/2017	Kolleen T Kennedy	EVP	Sell	2,021	$104.73	$211,659.33	27,688
7/12/2017	John W Kuo	SVP	Sell	863	$104.48	$90,166.24	28,224
7/12/2017	Kolleen T Kennedy	EVP	Sell	1,088	$104.49	$113,685.12	27,688
7/10/2017	Dow R Wilson	Insider	Sell	15,060	$103.37	$1,556,752.20	81,836
6/20/2017	Kolleen T Kennedy	EVP	Sell	26,092	$105.00	$2,739,660.00	52,692
6/13/2017	John W Kuo	SVP	Sell	734	$101.91	$74,801.94	28,095
6/12/2017	John W Kuo	SVP	Sell	863	$101.25	$87,378.75	28,224
6/12/2017	Kolleen T Kennedy	EVP	Sell	1,087	$101.20	$110,004.40	27,687
6/9/2017	Timothy E Guertin	Director	Sell	16,000	$103.22	$1,651,520.00	2,161
6/8/2017	Mark R Laret	Director	Sell	1,428	$103.47	$147,755.16	3,289
6/1/2017	Kolleen T Kennedy	EVP	Sell	56,573	$99.76	$5,643,722.48	32,737
5/31/2017	John W Kuo	SVP	Sell	19,819	$99.67	$1,975,359.73	47,180
5/12/2017	John W Kuo	SVP	Sell	862	$96.39	$83,088.18	28,223
5/2/2017	Susan L Bostrom	Director	Sell	3,589	$91.08	$326,886.12	3,809
4/12/2017	John W Kuo	SVP	Sell	864	$89.74	$77,535.36	27,914
3/17/2017	John W Kuo	SVP	Sell	3,876	$91.75	$355,623.00	30,926
3/13/2017	John W Kuo	SVP	Sell	862	$87.89	$75,761.18	27,912
3/1/2017	John W Kuo	SVP	Sell	10,353	$84.81	$878,037.93	37,403
1/5/2017	Dow R Wilson	Insider	Sell	13,334	$88.74	$1,183,259.16	77,625
12/8/2016	John W Kuo	SVP	Sell	1,267	$90.33	$114,448.11	24,027
12/5/2016	Dow R Wilson	Insider	Sell	10,000	$90.03	$900,300.00	74,291
11/7/2016	Dow R Wilson	Insider	Sell	10,000	$90.59	$905,900.00	70,598
10/31/2016	Timothy E Guertin	Director	Sell	4,000	$90.32	$361,280.00
10/20/2016	John W Kuo	SVP	Sell	21,266	$103.70	$2,205,284.20	45,293
10/5/2016	Dow R Wilson	Insider	Sell	10,000	$99.44	$994,400.00	70,598
10/3/2016	Elisha W Finney	CFO	Sell	4,668	$98.87	$461,525.16	9,863
9/15/2016	John W Kuo	SVP	Sell	4,073	$95.47	$388,849.31	28,100
9/7/2016	Elisha W Finney	CFO	Sell	9,000	$96.95	$872,550.00	14,195
9/6/2016	Dow R Wilson	Insider	Sell	10,000	$96.08	$960,800.00	70,598
9/1/2016	Elisha W Finney	CFO	Sell	2,000	$95.82	$191,640.00	7,195
8/5/2016	Dow R Wilson	Insider	Sell	10,000	$95.14	$951,400.00	70,598
8/1/2016	Clarence R Verhoef	SVP	Sell	9,483	$94.88	$899,747.04	8,616
8/1/2016	Elisha W Finney	CFO	Sell	25,334	$94.90	$2,404,196.60	7,195
8/1/2016	Timothy E. Guertin	Director	Sell	4,000	$94.88	$379,520.00
7/5/2016	Dow R Wilson	CEO	Sell	10,000	$82.08	$820,800.00	70,598
6/27/2016	Dow R Wilson	CEO	Sell	10,000	$78.27	$782,700.00	70,598
6/8/2016	Ruediger Naumann-Etienne	Director	Sell	1,000	$84.83	$84,830.00
6/3/2016	Mark R Laret	Director	Sell	1,545	$83.48	$128,976.60	1,428
5/2/2016	Timothy E. Guertin	Director	Sell	4,000	$81.55	$326,200.00
4/20/2016	Elisha W Finney	CFO	Sell	4,000	$85.95	$343,800.00	9,011
4/18/2016	Clarence R Verhoef	SVP	Sell	2,500	$85.00	$212,500.00	8,445
3/23/2016	Dow R Wilson	CEO	Sell	45,650	$78.86	$3,599,959.00	105,931
3/10/2016	Ruediger Naumann-Etienne	Director	Sell	428	$77.99	$33,379.72	1,000
3/7/2016	Timothy E. Guertin	Director	Sell	4,000	$79.47	$317,880.00
2/17/2016	Elisha W. Finney	CFO	Sell	2,454	$78.59	$192,859.86	5,011
12/7/2015	Dow R. Wilson	CEO	Sell	9,000	$80.00	$720,000.00	44,943
12/2/2015	R Andrew Eckert	Director	Sell	3,000	$81.67	$245,010.00	7,016
11/24/2015	Elisha W. Finney	CFO	Sell	2,334	$80.90	$188,820.60	5,011
11/6/2015	Dow R. Wilson	CEO	Sell	18,000	$80.26	$1,444,680.00	38,767
9/8/2015	Dow R. Wilson	CEO	Sell	9,000	$80.05	$720,450.00	38,767
7/6/2015	Dow R Wilson	CEO	Sell	9,000	$85.80	$772,200.00
7/2/2015	Elisha W Finney	CFO	Sell	2,000	$85.95	$171,900.00
7/1/2015	Timothy E Guertin	Director	Sell	25,000	$84.20	$2,105,000.00
6/5/2015	Dow R Wilson	CEO	Sell	9,000	$86.29	$776,610.00
6/1/2015	Elisha W Finney	CFO	Sell	2,000	$85.99	$171,980.00
6/1/2015	Timothy E Guertin	Director	Sell	25,000	$86.08	$2,152,000.00
5/6/2015	Dow R Wilson	CEO	Sell	9,000	$86.64	$779,760.00
4/17/2015	Dow R Wilson	CEO	Sell	18,760	$93.63	$1,756,498.80
4/1/2015	Elisha W Finney	CFO	Sell	5,000	$92.76	$463,800.00
4/1/2015	Timothy E Guertin	Director	Sell	25,000	$92.76	$2,319,000.00
3/20/2015	Dow R Wilson	CEO	Sell	18,759	$94.44	$1,771,599.96
3/16/2015	Kolleen T Kennedy	EVP	Sell	1,972	$95.00	$187,340.00
3/6/2015	Timothy E Guertin	Director	Sell	4,000	$93.50	$374,000.00
3/2/2015	Elisha W Finney	CFO	Sell	5,000	$93.44	$467,200.00
3/2/2015	Timothy E Guertin	Director	Sell	50,000	$93.48	$4,674,000.00
2/23/2015	Elisha W Finney	CFO	Sell	1,326	$92.97	$123,278.22
2/10/2015	Mark R Laret	Director	Sell	10,000	$92.32	$923,200.00
2/3/2015	Venkatraman Thyagarajan	Director	Sell	10,000	$92.71	$927,100.00
2/2/2015	Dow R Wilson	CEO	Sell	60,000	$91.78	$5,506,800.00
2/2/2015	Elisha W Finney	CFO	Sell	6,667	$91.79	$611,963.93
2/2/2015	John W Kuo	SVP	Sell	3,490	$92.04	$321,219.60
2/2/2015	Ruediger Naumann-Etienne	Director	Sell	10,000	$91.87	$918,700.00
1/5/2015	Timothy E Guertin	Director	Sell	50,000	$86.27	$4,313,500.00
1/2/2015	Elisha W Finney	CFO	Sell	15,000	$87.05	$1,305,750.00
12/11/2014	Timothy E Guertin	Director	Sell	105,000	$86.67	$9,100,350.00
12/1/2014	Elisha W Finney	CFO	Sell	21,000	$88.72	$1,863,120.00
11/24/2014	Elisha W Finney	CFO	Sell	2,930	$88.24	$258,543.20
11/17/2014	Elisha W Finney	CFO	Sell	1,837	$87.71	$161,123.27
11/11/2014	Kolleen T Kennedy	SVP	Sell	1,242	$85.79	$106,551.18
11/10/2014	Ruediger Naumann-Etienne	Director	Sell	5,000	$85.31	$426,550.00
11/3/2014	Elisha W Finney	CFO	Sell	25,000	$83.82	$2,095,500.00
11/3/2014	Timothy E Guertin	Director	Sell	80,000	$83.72	$6,697,600.00
10/29/2014	Elisha W Finney	CFO	Sell	10,000	$83.95	$839,500.00
10/27/2014	Kolleen T Kennedy	SVP	Sell	1,240	$81.00	$100,440.00
10/1/2014	Elisha W Finney	CFO	Sell	15,000	$79.98	$1,199,700.00
9/11/2014	John W Kuo	SVP	Sell	605	$85.82	$51,921.10
9/2/2014	Elisha W Finney	CFO	Sell	20,000	$85.18	$1,703,600.00
8/20/2014	Venkatraman Thyagarajan	Director	Sell	5,000	$84.25	$421,250.00
8/7/2014	Elisha W Finney	CFO	Sell	5,000	$83.95	$419,750.00
8/1/2014	Elisha W Finney	CFO	Sell	15,000	$81.66	$1,224,900.00
8/1/2014	Timothy E Guertin	Director	Sell	80,000	$81.69	$6,535,200.00
7/9/2014	John W Kuo	SVP	Sell	582	$85.00	$49,470.00
7/1/2014	Elisha W Finney	CFO	Sell	20,000	$83.86	$1,677,200.00
6/23/2014	John W Kuo	SVP	Sell	1,745	$85.00	$148,325.00
6/16/2014	Kolleen T Kennedy	SVP	Sell	1,416	$82.42	$116,706.72
6/2/2014	Elisha W Finney	CFO	Sell	10,000	$82.35	$823,500.00
5/12/2014	Kolleen Kennedy	SVP	Sell	1,417	$81.96	$116,137.32	6,236
5/1/2014	Elisha Finney	CFO	Sell	10,000	$78.99	$789,900.00	4,496
5/1/2014	Timothy Guertin	Director	Sell	80,000	$78.98	$6,318,400.00	48,683
4/11/2014	Kolleen T Kennedy	SVP	Sell	640	$72.15	$46,176.00
4/1/2014	Elisha Finney	CFO	Sell	10,000	$83.97	$839,700.00	4,308
3/17/2014	Clarence Verhoef	SVP	Sell	1,140	$84.70	$96,558.00	768
3/11/2014	Kolleen Kennedy	SVP	Sell	1,417	$84.39	$119,580.63	6,236
3/10/2014	Timothy Guertin	Director	Sell	80,000	$84.05	$6,724,000.00	48,683
3/3/2014	Elisha Finney	CFO	Sell	10,000	$83.41	$834,100.00	4,308
2/21/2014	Mark Laret	Director	Sell	1,411	$84.06	$118,608.66
2/11/2014	Kolleen Kennedy	SVP	Sell	1,416	$80.59	$114,115.44	6,236
2/10/2014	R Andrew Eckert	Director	Sell	5,887	$80.52	$474,021.24	4,983
2/3/2014	Elisha Finney	CFO	Sell	10,000	$79.34	$793,400.00	4,308
2/3/2014	Timothy Guertin	Director	Sell	27,000	$79.34	$2,142,180.00	48,683
1/31/2014	Susan Bostrom	Director	Sell	18,900	$81.50	$1,540,350.00	853
1/2/2014	Elisha Finney	CFO	Sell	24,321	$77.69	$1,889,498.49	4,308
1/2/2014	Richard Levy	Director	Sell	20,000	$77.68	$1,553,600.00
12/30/2013	John Kuo	SVP	Sell	3,027	$77.08	$233,321.16	13,720
12/23/2013	Clarence Verhoef	SVP	Sell	1,297	$76.13	$98,740.61	1,908
12/9/2013	Dow Wilson	CEO	Sell	95,000	$79.09	$7,513,550.00	51,474
12/4/2013	Robert Kluge	SVP	Sell	12,932	$80.00	$1,034,560.00	20,347
12/2/2013	Elisha Finney	CFO	Sell	10,000	$79.04	$790,400.00	8,629
12/2/2013	Richard Levy	Director	Sell	20,000	$79.04	$1,580,800.00
12/2/2013	Robert Kluge	SVP	Sell	9,889	$79.00	$781,231.00	33,279
11/29/2013	Kolleen Kennedy	SVP	Sell	9,307	$78.00	$725,946.00	6,236
11/25/2013	Kolleen Kennedy	SVP	Sell	2,972	$75.49	$224,356.28	6,236
11/22/2013	Elisha Finney	CFO	Sell	1,617	$74.83	$121,000.11	8,629
11/14/2013	Elisha Finney	CFO	Sell	5,000	$74.95	$374,750.00	7,316
11/1/2013	Elisha W Finney	CFO	Sell	5,000	$72.27	$361,350.00
11/1/2013	Richard M Levy	Director	Sell	20,000	$72.27	$1,445,400.00
10/14/2013	Robert Kluge	SVP	Sell	13,889	$78.00	$1,083,342.00	30,121
10/10/2013	Robert Kluge	SVP	Sell	13,871	$77.00	$1,068,067.00	30,121
9/20/2013	Kolleen Kennedy	SVP	Sell	1,247	$76.00	$94,772.00	6,236
9/16/2013	Elisha Finney	CFO	Sell	16,334	$74.95	$1,224,233.30	7,108
9/16/2013	Kolleen Kennedy	SVP	Sell	2,562	$75.00	$192,150.00	7,483
9/11/2013	Elisha W Finney	CFO	Sell	23,666	$74.95	$1,773,766.70
9/3/2013	Elisha Finney	CFO	Sell	5,000	$70.95	$354,750.00	7,108
9/3/2013	Richard Levy	Director	Sell	20,000	$70.95	$1,419,000.00
8/8/2013	Kolleen Kennedy	SVP	Sell	2,400	$73.50	$176,400.00	7,483
8/1/2013	Elisha W Finney	CFO	Sell	5,000	$72.81	$364,050.00
8/1/2013	R Andrew Eckert	Director	Sell	1,375	$72.93	$100,278.75
7/19/2013	John W Kuo	SVP	Sell	1,817	$72.00	$130,824.00
7/17/2013	Richard M Levy	Director	Sell	20,000	$70.00	$1,400,000.00
7/16/2013	Elisha W Finney	CFO	Sell	5,000	$69.95	$349,750.00
6/17/2013	Elisha W Finney	CFO	Sell	5,000	$69.95	$349,750.00
6/17/2013	Richard M Levy	Director	Sell	20,000	$70.00	$1,400,000.00
6/10/2013	Timothy E Guertin	Director	Sell	27,000	$68.81	$1,857,870.00
5/21/2013	Elisha W Finney	CFO	Sell	2,313	$69.86	$161,586.18
5/14/2013	Elisha W Finney	CFO	Sell	5,000	$69.95	$349,750.00
5/14/2013	John W Kuo	SVP	Sell	1,112	$70.00	$77,840.00
5/14/2013	Richard M Levy	Director	Sell	20,000	$70.00	$1,400,000.00
2/14/2013	John W Kuo	SVP	Sell	1,111	$71.05	$78,936.55
9/4/2012	Kolleen T Kennedy	SVP	Sell	1,900	$64.00	$121,600.00
8/20/2012	Elisha W Finney	CFO	Sell	4,000	$59.95	$239,800.00

(Data available from 1/1/2013 forward)

Varian Medical Systems (NYSE VAR) News Headlines

Source:

Date	Headline
	Varian Medical Systems (VAR) Informed Sirtex that it Will not be Providing Counter Proposal to CDH-CGP Offer www.streetinsider.com - June 14 at 5:17 PM
	Varian Provides Update on Proposed Sirtex Acquisition finance.yahoo.com - June 14 at 5:17 PM
	Australia's Sirtex Medical accepts $1.4 bln offer from China's CDH Investments finance.yahoo.com - June 14 at 8:37 AM
	BRIEF-Sirtex Medical Enters Binding Scheme Implementation Deed With CDH Genetech And China Grand Pharma finance.yahoo.com - June 14 at 8:37 AM
	Australia's Sirtex picks China CDH's $1.4 bln offer over U.S.-based Varian's finance.yahoo.com - June 14 at 8:37 AM
	Here's Why You Should Buy Varian Medical (VAR) Stock Now www.zacks.com - June 13 at 8:35 AM
	Riverside Introduces the Varian Edge™ Radiosurgery Suite to its Dedicated Radiosurgery Center www.bizjournals.com - June 12 at 4:53 PM
	Analyzing Varian’s Valuation finance.yahoo.com - June 11 at 5:02 PM
	Varian Announces Third Quarter Fiscal Year 2018 Earnings Release Date finance.yahoo.com - June 11 at 5:02 PM
	Varian Medical Systems, Inc. (VAR) Given Consensus Rating of "Hold" by Brokerages www.americanbankingnews.com - June 9 at 1:34 AM
	Radiotherapy Devices Market is Supposed to Reach US$ 7.5 Billion By 2024 www.marketwatch.com - June 8 at 8:31 AM
	Zacks: Analysts Anticipate Varian Medical Systems, Inc. (VAR) Will Post Quarterly Sales of $671.10 Million www.americanbankingnews.com - June 7 at 4:06 AM
	Varian Medical Systems, Inc. (VAR) Expected to Post Earnings of $1.00 Per Share www.americanbankingnews.com - June 5 at 1:00 PM
	Varian to Demonstrate Advanced Brachytherapy Solutions at ABS 2018 finance.yahoo.com - June 5 at 8:30 AM
	4 Medical Device Stocks with Solid Potential to Buy Now finance.yahoo.com - June 1 at 5:21 PM
	Varian Medical Systems (VAR) and BioSig Technologies (BSGM) Financial Review www.americanbankingnews.com - June 1 at 3:31 PM
	Varian Halcyon Systems Expand Access to Cancer Care at Three Centers in Africa finance.yahoo.com - May 30 at 8:40 AM
	Intuitive Surgical Commences Direct Operations in India finance.yahoo.com - May 30 at 8:40 AM
	X-Ray Detectors Market is Supposed to Reach US$ 3.00 Billion By 2024 www.marketwatch.com - May 29 at 5:08 PM
	Merit Medical (MMSI) Up 18.9% in a Month on Solid Q1 Earnings finance.yahoo.com - May 28 at 8:38 AM
	Why is Varian Medical Systems (VAR) Down 5.5% Since its Last Earnings Report? www.zacks.com - May 25 at 5:30 PM
	Varian to Present at Jefferies Global Healthcare Conference finance.yahoo.com - May 23 at 5:21 PM
	Complimentary Technical Snapshots on Prestige Brands and Three More Medical Equipment Stocks finance.yahoo.com - May 23 at 8:32 AM
	Australia's Sirtex Medicals gets binding offer from China's CDH finance.yahoo.com - May 22 at 8:33 AM
	Varian Notifies Sirtex It Will Not Submit a Counterproposal to Competing Bid finance.yahoo.com - May 22 at 8:33 AM
	Varian says will not match Chinese bid for Australia's Sirtex finance.yahoo.com - May 22 at 8:33 AM
	$671.10 Million in Sales Expected for Varian Medical Systems, Inc. (VAR) This Quarter www.americanbankingnews.com - May 21 at 4:36 AM
	Radiotherapy Market is Determined to Cross US$ 8.50 Billion By 2022 www.marketwatch.com - May 20 at 5:41 PM
	$1.00 Earnings Per Share Expected for Varian Medical Systems (VAR) This Quarter www.americanbankingnews.com - May 19 at 5:19 AM
	Varian Medical (VAR) Merges With Brazil MOH to Fight Cancer www.zacks.com - May 18 at 9:05 AM
	Cerner's (CERN) EHR Picked by Crisp Regional, Shares Up www.zacks.com - May 17 at 8:43 AM
	Varian Signs Training and Education Cooperation Agreement with Brazil Ministry of Health and Science and ... www.prnewswire.com - May 17 at 8:43 AM
	Varian Signs Training and Education Cooperation Agreement with Brazil Ministry of Health and Science and Technology Institutions finance.yahoo.com - May 17 at 8:43 AM
	Varian Medical Systems (VAR) SVP Sells $155,458.05 in Stock www.americanbankingnews.com - May 16 at 4:21 PM
	Glancy Prongay & Murray LLP Continues Investigation on Behalf of Varian Medical Systems, Inc. (VAR) Investors www.bizjournals.com - May 16 at 8:43 AM
	First Cancer Patients in Korea Treated with Varian HyperArc High-Definition Radiotherapy finance.yahoo.com - May 16 at 8:43 AM
	Echo Therapeutics (ECTE) vs. Varian Medical Systems (VAR) Critical Contrast www.americanbankingnews.com - May 16 at 5:28 AM
	Recent Analysis Shows Liberty Broadband, Primerica, Adtalem Global Education, Newpark Resources, Varian Medical, and Eagle Materials Market Influences — Renewed Outlook, Key Drivers of Growth finance.yahoo.com - May 15 at 8:51 AM
	Varian Medical Systems (VAR) Receives Average Rating of "Hold" from Brokerages www.americanbankingnews.com - May 15 at 1:38 AM
	Varian Medical Systems (VAR) EVP Sells $82,621.80 in Stock www.americanbankingnews.com - May 11 at 8:23 PM
	Here's Why You Should Invest in Varian Medical (VAR) Now www.zacks.com - May 11 at 8:58 AM
	Global Brachytherapy Therapy Market 2018-2024: Key Players are Elekta, Varian Medical Systems, C.R. Bard, Eckert & Ziegler BEBIG and Theragenics globenewswire.com - May 9 at 8:39 AM
	DaVita (DVA) Beats Q1 Earnings Estimates, Reiterates View finance.yahoo.com - May 8 at 5:19 PM
	BRIEF-Varian Acquires Taiwan Distributor www.reuters.com - May 7 at 8:35 AM
	Windfall: Sirtex Medical Limited receives second takeover bid at $33.60 www.fool.com.au - May 7 at 8:35 AM
	Varian Medical Systems (VAR) to Acquire Taiwan's Cooperative CL Enterprises www.streetinsider.com - May 7 at 8:35 AM
	Varian Acquires Taiwan Distributor finance.yahoo.com - May 7 at 8:35 AM
	Varian acquisition target Sirtex Medical receives new offer from Chinese investor, shareholders meeting postponed seekingalpha.com - May 4 at 8:34 AM
	China's CDH Investments makes $1.4 bln offer for Sirtex, trumps Varian bid www.nasdaq.com - May 4 at 8:34 AM
	Chinese firm makes last-minute $1.4 bln offer for Australia's Sirtex, trumps Varian finance.yahoo.com - May 4 at 8:34 AM

Varian Medical Systems (NYSE:VAR) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Varian Medical Systems (NYSE:VAR) Income Statement, Balance Sheet and Cash Flow Statement

Varian Medical Systems (NYSE VAR) Stock Chart for Sunday, June, 17, 2018

Loading chart…

This page was last updated on 6/17/2018 by MarketBeat.com Staff